American Oriental Bioengineering (AOB) Proposes Offering of $85 Million of Convertible Notes; Issues A Buyback of $30 Million
More News related to AOB
- Lazard Downgrades American Oriental (AOB) to Hold
- American Oriental Bioengineering Announces Participation in September Investor Conferences
- Matrix USA Rating Changes 9/2
- Piper Jaffray Downgrades American Oriental Bioengineering (AOB) to Neutral
- American Oriental Bioengineering (AOB) Tops Q2 EPS by 1c, Guides In-line for FY Revenues
More News related to Stock Buybacks
- Cenveo (CVO) Announces $15M Buyback; Backs Q3 Adj-EBITDA Guidance
- Micrel (MCRL) Adds $10M to Buyback
- Alcoa (AA) Reports Q3 Adj-EPS of $0.37; Suspends Share Buyback
- Teekay (TK) Increases Dividend and Approves $200 Million Stock Buyback
- Peoples Financial (PFBX) Approves Stock Buyback Plan
American Oriental Bioengineering, Inc. (NYSE: AOB) announced its intention to offer, subject to market conditions and other factors, $85 million aggregate principal amount of Convertible Senior Notes due 2015 to qualified institutional buyers in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended.
American Oriental Bioengineering currently expects to use approximately $30 million of the proceeds from the offering to repurchase shares of its common stock pursuant to a prepaid forward share repurchase transaction with an affiliate of the placement agent, as counterparty.
Related Categories
Corporate NewsEquity Offerings
Stock Buybacks
Stocks Mentioned
-0.42Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
